RhumbLine Advisers’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Sell |
105,212
-7,173
| -6% | -$26.3K | ﹤0.01% | 2846 |
|
|
2025
Q1 | $485K | Sell |
112,385
-2,881
| -2% | -$12.4K | ﹤0.01% | 2593 |
|
|
2024
Q4 | $369K | Buy |
115,266
+7,621
| +7% | +$24.4K | ﹤0.01% | 2854 |
|
|
2024
Q3 | $308K | Sell |
107,645
-5,367
| -5% | -$15.3K | ﹤0.01% | 3011 |
|
|
2024
Q2 | $316K | Buy |
113,012
+3,436
| +3% | +$9.62K | ﹤0.01% | 2965 |
|
|
2024
Q1 | $311K | Buy |
109,576
+3,151
| +3% | +$8.95K | ﹤0.01% | 2959 |
|
|
2023
Q4 | $435K | Sell |
106,425
-1,030
| -1% | -$4.21K | ﹤0.01% | 2742 |
|
|
2023
Q3 | $342K | Buy |
107,455
+2,841
| +3% | +$9.03K | ﹤0.01% | 2855 |
|
|
2023
Q2 | $347K | Buy |
104,614
+15,910
| +18% | +$52.8K | ﹤0.01% | 2919 |
|
|
2023
Q1 | $189K | Sell |
88,704
-122,083
| -58% | -$260K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $567K | Buy |
210,787
+16,099
| +8% | +$43.3K | ﹤0.01% | 2407 |
|
|
2022
Q3 | $631K | Buy |
194,688
+16,804
| +9% | +$54.5K | ﹤0.01% | 2389 |
|
|
2022
Q2 | $868K | Buy |
177,884
+19,833
| +13% | +$96.8K | ﹤0.01% | 2212 |
|
|
2022
Q1 | $1.2M | Buy |
158,051
+39,208
| +33% | +$299K | ﹤0.01% | 2058 |
|
|
2021
Q4 | $1.1M | Buy |
118,843
+3,481
| +3% | +$32.2K | ﹤0.01% | 2169 |
|
|
2021
Q3 | $1.64M | Sell |
115,362
-2,275
| -2% | -$32.4K | ﹤0.01% | 2004 |
|
|
2021
Q2 | $1.96M | Buy |
117,637
+99,993
| +567% | +$1.66M | ﹤0.01% | 1962 |
|
|
2021
Q1 | $321K | Buy |
17,644
+3,556
| +25% | +$64.7K | ﹤0.01% | 2681 |
|
|
2020
Q4 | $106K | Buy |
14,088
+1,760
| +14% | +$13.2K | ﹤0.01% | 2964 |
|
|
2020
Q3 | $47K | Sell |
12,328
-3,495
| -22% | -$13.3K | ﹤0.01% | 2953 |
|
|
2020
Q2 | $61K | Buy |
+15,823
| New | +$61K | ﹤0.01% | 3018 |
|